Eclampsia: Maternal and Fetal Outcome

Abstract

ABSTRACT Eclampsia is the leading cause of maternal and perinatal mortality as well as morbidity. This prospective study was carried out at a tertiary institute from Jan 2008 to Dec 2010. Aim and objectives (1) To evaluate the rate of eclampsia in antenatal women attending our hospital, (2) to evaluate the epidemiological factors and clinical presentation in women with eclampsia, (3) to analyze the maternal and perinatal outcome in women with eclampsia, and (4) to formulate strategies to improve the maternal and perinatal outcome. Materials and methods Fifty-five women with eclampsia were evaluated over a period of 3 years. Results During the above period, total number of deliveries were 6,100 out of which 55 were eclampsia giving incidence of —0.9%. The women with eclampsia were treated with magnesium sulfate. Around 70.91% of women had antenatal eclampsia, 18.18% of women had intrapartum eclampsia and 10.91% of women had postpartum eclampsia. Out of 55 women, maternal mortality was 5.45% and perinatal mortality was 25.45%. Conclusion Incidence of eclampsia is higher in developing countries, like India. Magnesium sulfate is an effective anticonvulsant drug leading to cessation of convulsions in 100% cases. Magnesium sulfate toxicity was not observed in any case, indicating effectivity of clinical monitoring during magnesium sulfate therapy. How to cite this article Bhalerao A, Kulkarni S, Ghike S, Kawthalkar A, Joshi S, Somalwar S. Eclampsia: Maternal and Fetal Outcome. J South Asian Feder Obst Gynae 2013;5(1): 19-21.